ATE454136T1 - Therapeutische zusammensetzungen zur pulmonalen verabreichung - Google Patents

Therapeutische zusammensetzungen zur pulmonalen verabreichung

Info

Publication number
ATE454136T1
ATE454136T1 AT01907916T AT01907916T ATE454136T1 AT E454136 T1 ATE454136 T1 AT E454136T1 AT 01907916 T AT01907916 T AT 01907916T AT 01907916 T AT01907916 T AT 01907916T AT E454136 T1 ATE454136 T1 AT E454136T1
Authority
AT
Austria
Prior art keywords
therapeutic compositions
pulmonary administration
therapeutic agent
microparticles
obtainable
Prior art date
Application number
AT01907916T
Other languages
English (en)
Inventor
Glen P Martyn
Original Assignee
Quadrant Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Drug Delivery Ltd filed Critical Quadrant Drug Delivery Ltd
Application granted granted Critical
Publication of ATE454136T1 publication Critical patent/ATE454136T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
AT01907916T 2000-02-29 2001-02-27 Therapeutische zusammensetzungen zur pulmonalen verabreichung ATE454136T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0004827.2A GB0004827D0 (en) 2000-02-29 2000-02-29 Compositions
PCT/GB2001/000834 WO2001064188A1 (en) 2000-02-29 2001-02-27 Therapeutic compositions for pulmonary delivery

Publications (1)

Publication Number Publication Date
ATE454136T1 true ATE454136T1 (de) 2010-01-15

Family

ID=9886657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01907916T ATE454136T1 (de) 2000-02-29 2001-02-27 Therapeutische zusammensetzungen zur pulmonalen verabreichung

Country Status (11)

Country Link
US (2) US20030133879A1 (de)
EP (1) EP1259228B1 (de)
JP (1) JP2003525232A (de)
AT (1) ATE454136T1 (de)
AU (1) AU2001235783A1 (de)
CA (1) CA2401696A1 (de)
DE (1) DE60140997D1 (de)
ES (1) ES2339423T3 (de)
GB (1) GB0004827D0 (de)
PT (1) PT1259228E (de)
WO (1) WO2001064188A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011807D0 (en) * 2000-05-16 2000-07-05 Quadrant Holdings Cambridge Formulation for inhalation
US6749845B2 (en) * 2001-02-15 2004-06-15 Aeropharm Technology, Inc. Modulated release particles for lung delivery
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2004532277A (ja) 2001-06-08 2004-10-21 パウダージェクト ワクチンズ，インコーポレーテッド 噴霧凍結乾燥組成物
AU2002342241B2 (en) 2001-11-01 2007-07-19 Novartis Ag Spray drying methods and compositions thereof
KR20050044523A (ko) * 2001-11-19 2005-05-12 벡톤 디킨슨 앤드 컴퍼니 입자 형태의 약제학적 조성물
GB0129489D0 (en) * 2001-12-10 2002-01-30 Quadrant Healthcare Uk Ltd Sustained-release compositions
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB2399084B (en) * 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
DE10339197A1 (de) * 2003-08-22 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
US7723712B2 (en) * 2006-03-17 2010-05-25 Micron Technology, Inc. Reduced power consumption phase change memory and methods for forming the same
KR20140034853A (ko) * 2011-05-30 2014-03-20 노보자임스 바이오파마 디케이 에이/에스 고분자량 히알루론산의 분무 건조
EP2938664A4 (de) * 2012-12-28 2016-08-24 Nathan T Starbard Poröse polymerpartikel und verfahren zur herstellung und verwendung davon
US20160243154A1 (en) * 2013-10-23 2016-08-25 Donald W. Jessup Hyaluronic acid formulation
CN109531857B (zh) * 2019-01-02 2020-11-06 华熙生物科技股份有限公司 一种透明质酸或其盐颗粒的制备方法及所得产品
WO2023224577A1 (en) * 2022-05-18 2023-11-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising micronized human insulin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0739339B2 (ja) * 1989-05-01 1995-05-01 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 生物活性を有する分子の小粒子の製造方法
US5208998A (en) * 1991-02-25 1993-05-11 Oyler Jr James R Liquid substances freeze-drying systems and methods
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
DE69332240T2 (de) * 1992-06-12 2003-04-10 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
AU4198793A (en) * 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
JPH08301762A (ja) * 1995-05-12 1996-11-19 Teijin Ltd 肺癌治療剤
US5922253A (en) * 1995-05-18 1999-07-13 Alkermes Controlled Therapeutics, Inc. Production scale method of forming microparticles
WO1997002738A1 (fr) * 1995-07-12 1997-01-30 Kabushikikaisha Daiki Materiau d'elimination des dejections animales et procede de production de ce materiau
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
JP4266399B2 (ja) * 1997-12-04 2009-05-20 帝人株式会社 粉末状吸入用医薬品組成物
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
CA2367131C (en) * 1999-04-05 2007-07-03 Solomon S. Steiner Methods for fine powder formation
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles

Also Published As

Publication number Publication date
US20030133879A1 (en) 2003-07-17
AU2001235783A1 (en) 2001-09-12
ES2339423T3 (es) 2010-05-20
JP2003525232A (ja) 2003-08-26
WO2001064188A1 (en) 2001-09-07
DE60140997D1 (de) 2010-02-25
GB0004827D0 (en) 2000-04-19
CA2401696A1 (en) 2001-09-07
EP1259228B1 (de) 2010-01-06
PT1259228E (pt) 2010-04-07
US20080112896A1 (en) 2008-05-15
EP1259228A1 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
DE60140997D1 (de) Therapeutische zusammensetzungen zur pulmonalen verabreichung
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DK1318788T3 (da) Nanopartikulær fastdosissammensætninger
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
TW200605870A (en) Topical methadone compositions and methods for using the same
AU5367501A (en) Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
AU2003274681A8 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
DE60326859D1 (de) Arzneimittelverabreichung
AR053977A1 (es) Composiciones farmaceuticas con enmascaramiento de sabor
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2003066597A3 (en) Guanidino compounds
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
WO2003053413A3 (en) Sustained-release compositions
EE200300279A (et) Toimeaine parendatud vabanemisprofiiliga mikroosakesed ja nende valmistamise meetod
DE50114127D1 (de) Torasemid enthaltende lagerstabile pharmazeutische zubereitungen
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1259228

Country of ref document: EP

REN Ceased due to non-payment of the annual fee